News and Press Releases
Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors
OKN4395 is the first Owkin development program to leverage K1.0, Owkin’s AI-powered Operating System, from asset selection to clinical development optimization This asset is a highly selective triple inhibitor of...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 30, 2025
Clinigen Announces Strategic Partnership with Tepsivo
Expanding Client Choice with AI-Powered Pharmacovigilance Solutions 27 January 2025 -- London, UK -- Clinigen, the global specialist pharmaceutical services company, today announced a strategic partnership with Tepsivo, a pioneering...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 27, 2025
Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring
Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use...
Category: Biotechnology, Other, Pharmaceutical
Posted: December 17, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
Accelerating Innovation in Research and Diagnostics with Science-Aware AI
10 December 2024 –Baltimore, MD, US – Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: December 10, 2024
Slow uptake of centralised data processes is preventing analytic maturity in manufacturing and supply chain firms, research reveals
Research from Alteryx finds that significant portions of the sector are missing out on more streamlined data analytics functions 5 November 2024 – London, UK – Decentralised data and processes...
Category: Logistics, Manufacturing and Packing
Posted: November 7, 2024
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
5 November 2024 –Tokyo, Japan and London and Cardiff, UK – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio...
Category: BioManufacturing
Posted: November 6, 2024
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
Science-driven collaboration ameliorates neurological assessments and endpoint data quality, enhances the rater and patient experience, and integrates Medidata App innovations with Cogstate capabilities 29 October 2024 -- New York, US...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: October 29, 2024
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharma and biotech projects Funding to progress internal...
Category: Biotechnology, Drug Discovery
Posted: October 17, 2024
PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS
Leading life sciences technology companies to simplify clinical research activities and improve operational processes with integrated software solution 3 October 2024 -- Nottingham, UK and California, US -- PHARMASEAL specializes...
Category: Clinical Trials, Drug Discovery, Logistics
Posted: October 3, 2024
Ingenuity Centre, Nottingham University Innovation Park Triumph Road, Nottingham, NG7 2TU, United Kingdom
Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer
2 October 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 2, 2024
RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System
First-in-human cases successfully completed using this new system at Baptist Health, Jacksonville, Florida 23 September 2024, – London, UK – RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK...
Category: Biotechnology, Clinical Trials
Posted: September 23, 2024
AGREEMENT WITH RECURSION PHARMACEUTICALS
New pharma agreement for Parsortix CTC analysis 19 September 2024 -- Guilford, UK -- ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: September 19, 2024
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...
Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
AI can detect lung nodules that could lead to lung cancer nearly 3 years before symptoms and actual diagnosis, study finds
Evidence presented at 2024 World Conference on Lung Cancer highlights chest X-ray AI’s potential to detect lung nodules early and expedite patient care 10 September 2024 -- New York, US...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 10, 2024
C/O RODl & Partner Legal Limited, 170 Edmund Street, Birmingham, United Kingdom B3 2HB 74909
Abacus Medicine Pharma Services and Mirum Pharmaceuticals Sign Partnership Agreement for the Commercialization of Livmarli in the Nordics
10 September 2024 -- Copenhagen, Denmark -- Abacus Medicine Pharma Services (‘Abacus’) announces the signing of a partnership agreement with Mirum Pharmaceuticals, Inc. (‘Mirum’) for the commercialization of LIVMARLI® (maralixibat)...
Category: Drug Delivery, Other, Pharmaceutical
Posted: September 10, 2024
Kalvebod Brygge 35 1560 Copenhagen V Denmark
